Teladoc Health, Inc. (TDOC): Price and Financial Metrics
Teladoc Health, Inc. (TDOC)
Today's Latest Price: $222.23 USD
Updated Oct 20 7:00pm
Add TDOC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
TDOC Stock Summary
- With a one year PEG ratio of 2,137.05, Teladoc Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.08% of US stocks.
- The price/operating cash flow metric for Teladoc Health Inc is higher than 98.75% of stocks in our set with a positive cash flow.
- TDOC's price/sales ratio is 25.37; that's higher than the P/S ratio of 93.46% of US stocks.
- If you're looking for stocks that are quantitatively similar to Teladoc Health Inc, a group of peers worth examining would be HZNP, BL, EXAS, AKAM, and AYX.
- Visit TDOC's SEC page to see the company's official filings. To visit the company's web site, go to www.teladochealth.com.
TDOC Stock Price Chart Interactive Chart >
TDOC Price/Volume Stats
| Current price | $222.23 | 52-week high | $253.00 |
| Prev. close | $223.69 | 52-week low | $66.23 |
| Day low | $221.29 | Volume | 1,274,862 |
| Day high | $226.26 | Avg. volume | 3,131,709 |
| 50-day MA | $210.88 | Dividend yield | N/A |
| 200-day MA | $173.36 | Market Cap | 18.44B |
Teladoc Health, Inc. (TDOC) Company Bio
Teladoc Health provides telehealth services via mobile devices, the Internet, video, and phone to clients and their customers in the United States. The company was founded in 2002 and is based in Dallas, Texas.
TDOC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $222.23 | $115877.69 | 51703% |
Below please find a table outlining a discounted cash flow forecast for TDOC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Teladoc Health Inc ranked in the 99th percentile in terms of potential gain offered. Our DCF model suggests the stock is undervalued by 51956.83%; returns of such proportions should be viewed with some skepticism, though. As for the metrics that stood out in our discounted cash flow analysis of Teladoc Health Inc, consider:
- In the past 1 years, Teladoc Health Inc has a compound free cash flow growth rate of 6.42%; that's higher than 97.18% of free cash flow generating stocks in the Technology sector.
- The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than merely 15.51% of the free cash flow producing stocks we're observing.
- Teladoc Health Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -1.89. This coverage rate is greater than that of merely 17.08% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 50687% |
| 1% | 51195% |
| 2% | 51703% |
| 3% | 52211% |
| 4% | 52719% |
| 5% | 53226% |
ASX, ZNGA, ALYA, BL, and DCMYY can be thought of as valuation peers to TDOC, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...